Female Sexual Dysfunction- Management

Female sexual dysfunction refers to a group of sexual problems characterized by persistent or recurrent difficulties related to sexual desire, arousal, orgasm, or sexual pain that result in significant personal distress.

Sexual dysfunction in women may affect different phases of the sexual response cycle, including:

• Reduced sexual desire.

• Impaired sexual arousal.

• Difficulty achieving orgasm.

• Pain during sexual activity (dyspareunia).

A diagnosis is made when sexual difficulties are persistent or recurrent and cause personal distress, interpersonal difficulties, or reduced quality of life.

Female sexual dysfunction is a complex condition influenced by biological, psychological, social, and relationship factors. Effective management requires identification and treatment of contributing factors rather than focusing only on sexual symptoms.

Epidemiology

Female sexual dysfunction is common and affects women across all age groups. The prevalence increases with age, particularly during periods associated with hormonal changes such as menopause.

Reported prevalence varies depending on the population studied, diagnostic criteria used, cultural factors, and willingness of women to discuss sexual concerns.

Despite being common, female sexual dysfunction is frequently underdiagnosed because many women do not seek medical attention due to embarrassment, cultural barriers, or lack of awareness that treatment options exist.

Risk factors

Risk factors contributing to female sexual dysfunction include:

Psychological factors

• Depression

• Anxiety disorders

• Stress

• Fatigue

• Poor body image

• Previous physical or sexual abuse

• Fear or negative beliefs regarding sexual activity

Relationship factors

• Relationship conflicts

• Poor communication with partner

• Reduced emotional intimacy

• Sexual relationship difficulties

Biological and medical factors

• Menopause

• Genitourinary syndrome of menopause

• Endometriosis

• Chronic pelvic pain

• Diabetes mellitus

• Cardiovascular disease

• Neurological disorders

• Hormonal abnormalities

• Chronic illnesses affecting general wellbeing

Medication-related factors

• Selective serotonin reuptake inhibitors (SSRIs)

• Other antidepressants

• Hormonal medications

• Drugs affecting sexual response

Pathophysiology

Female sexual response involves interaction between psychological, neurological, hormonal, vascular, and genital factors.

Sexual desire and arousal are influenced by:

• Brain neurotransmitters.

• Sex hormones, particularly oestrogen and androgens.

• Emotional wellbeing.

• Relationship factors.

Disturbances in any of these pathways may result in reduced desire, impaired arousal, difficulty achieving orgasm, or sexual pain.

Reduced oestrogen levels during menopause may cause vaginal dryness, reduced genital blood flow, and thinning of vaginal tissues, resulting in discomfort and dyspareunia.

Psychological factors such as anxiety, depression, trauma, and relationship difficulties may interfere with sexual response and contribute to persistent symptoms.

Clinical presentation

Female sexual dysfunction may present with problems affecting one or more stages of sexual response.

Symptoms

Reduced sexual desire

• Reduced interest in sexual activity

• Decreased sexual thoughts or fantasies

• Reduced initiation of sexual activity

Impaired arousal

• Difficulty becoming sexually excited

• Reduced genital sensations

• Reduced vaginal lubrication

• Reduced sexual satisfaction

Orgasm difficulties

• Delayed orgasm

• Difficulty achieving orgasm

• Reduced intensity of orgasm

Sexual pain disorders

• Pain during sexual intercourse (dyspareunia)

• Vaginal discomfort

• Burning or irritation during sexual activity

Associated symptoms

• Emotional distress

• Anxiety related to sexual activity

• Relationship difficulties

• Reduced self-esteem

Clinical signs

Female sexual dysfunction often has no specific physical signs; however, examination may identify contributing conditions.

Possible findings include:

• Genital lesions

• Vaginal dryness

• Vaginal atrophy

• Pelvic tenderness

• Features of hormonal deficiency

• Signs of underlying medical conditions

Diagnostic criteria

Diagnosis requires:

• Persistent or recurrent sexual difficulties.

• Symptoms affecting sexual desire, arousal, orgasm, or causing sexual pain.

• Symptoms causing significant personal distress.

Assessment should include:

• Detailed sexual history.

• Medical history.

• Medication review.

• Psychological assessment.

• Evaluation of relationship factors.

• Physical examination when indicated.

Investigations

Investigations are guided by suspected underlying causes.

Possible investigations include:

Laboratory investigations

Where clinically indicated:

• Hormonal assessment

  • Thyroid function tests

  • Oestrogen levels

  • Other reproductive hormones

• Screening for underlying medical conditions:

  • Blood glucose testing

  • Other relevant metabolic investigations

Physical examination

May include:

• Pelvic examination to identify:

  • Genital lesions

  • Vaginal atrophy

  • Infection

  • Pelvic pathology

Psychological assessment

Assessment for:

• Depression

• Anxiety

• Psychological trauma

• Relationship difficulties

Management

Management should be individualized and directed toward identifying and correcting contributing factors.

Treatment involves:

• Addressing medical and hormonal causes.

• Managing psychological and relationship factors.

• Reviewing medications that may contribute to symptoms.

• Providing education and counselling.

Non-pharmacological treatment

Correction of contributing factors

Management should include treatment of:

• Genital lesions.

• Systemic medical conditions.

• Hormonal abnormalities.

• Medication-related causes.

Examples include:

• Reviewing and adjusting medications associated with sexual dysfunction, such as SSRIs, when clinically appropriate.

• Treating painful conditions such as endometriosis.

• Managing genitourinary symptoms associated with menopause.

Psychological therapies

Psychological interventions may include:

• Sexual counselling.

• Cognitive behavioural therapy.

• Psychotherapy.

• Couples therapy.

• Stress management techniques.

These approaches are particularly important where psychological factors, anxiety, trauma, or relationship problems contribute to symptoms.

Pharmacological treatment

Pharmacological treatment depends on the underlying cause.

Antidepressants

Antidepressants may be used when depression or anxiety contributes to sexual dysfunction.

However, some antidepressants, particularly SSRIs, may themselves contribute to sexual dysfunction and require careful review.

Hormonal therapy

Where symptoms are related to menopause or hormonal deficiency, appropriate hormonal treatment may be considered according to clinical indication.

Management should be individualized after assessment of risks and benefits.

Management according to underlying cause

Psychological causes

• Provide psychological counselling.

• Treat depression and anxiety.

• Address relationship difficulties.

Medication-related sexual dysfunction

• Review current medications.

• Consider alternative medications where appropriate.

• Avoid abrupt discontinuation of prescribed antidepressants.

Menopausal-related sexual dysfunction

• Manage vaginal dryness and discomfort.

• Address genitourinary symptoms of menopause.

• Consider appropriate hormonal therapy when indicated.

Pain-related sexual dysfunction

• Identify and treat causes such as:

  • Endometriosis

  • Pelvic inflammatory disease

  • Vaginal disorders

Referral

Referral is recommended for:

• Persistent symptoms despite initial management.

• Significant psychological distress.

• Suspected sexual trauma.

• Complex relationship difficulties.

• Suspected hormonal disorders.

• Chronic pelvic pain.

• Need for specialist sexual medicine or psychological support.

Referral may be made to:

• Gynaecologist

• Psychologist or psychiatrist

• Sexual health specialist

Complications

Untreated female sexual dysfunction may result in:

• Reduced quality of life

• Relationship difficulties

• Emotional distress

• Anxiety

• Depression

• Reduced self-esteem

• Avoidance of sexual intimacy

Prognosis

The prognosis depends on the underlying cause and response to treatment.

Many women improve significantly when contributing medical, psychological, and relationship factors are identified and appropriately managed. A multidisciplinary approach often provides the best outcomes.

Prevention

Prevention strategies include:

• Maintaining good physical and mental health.

• Seeking early treatment for depression and anxiety.

• Maintaining healthy communication within relationships.

• Addressing sexual concerns early.

• Avoiding untreated pelvic and genital conditions.

• Reviewing medications that may affect sexual function.

• Providing appropriate menopausal care.